Logo

Your Partner in Health and Wellness


Icon

Phone

+91 77100 08952

Icon

Email

novaofficialai@gmail.com

Icon

Location

123 Anywhere St., Any City, 12345

Be Our Subscribers

To get the latest news about health from our experts

Genito-Urinary Cancer

Contact Info

  • +123+456-7890
  • sarahlee@prohealth.com

Appointment Schedules

  • Monday 09.00-12.00
  • Wednesday 15.00-18.00
  • Friday 09.00-12.00

Dr. Richard Lee

MD, Ph.D

Clinical Co-Director, The Claire and John Bertucci Center for Genitourinary Cancers, Assistant Physician, Department of Medicine, Massachusetts General Hospital Boston, MA, USA

Degrees

  • University of California, San Francisco.

    Medical degree

  • University of California, Los Angeles (UCLA) Medical Center.

    Completed residency training in psychiatry

  • University of California, Berkeley.

    Master of Public Health degree

Experiences

  • Worked in community mental health clinics, private practice, and academic medical centers.

  • Expertise in the treatment of mood disorders, anxiety disorders, and psychotic disorders.

  • Special interest in womens mental health and perinatal psychiatry.

  • Experience managing complex cases that involve both mental health and medical issues.

Awards/Achievements

  • Fellow of the American Psychiatric Association (FAPA).

  • Recognized for research contributions with grants from the National Institute of Mental Health (NIMH) and the American Foundation for Suicide Prevention.

After completing a bachelor's and a master's degree at Harvard, Dr. Lee then completed his medical school (M.D.) and graduate school (Ph.D.) training at the Albert Einstein College of Medicine, in the Bronx, New York. He came to MGH for internal medicine residency training and then completed medical oncology fellowship training through the Dana-Farber Cancer Institute / MGH joint program. During that time, he performed basic science research at the Whitehead Institute of MIT. Since joining the staff at MGH, Dr. Lee has been engaged in translational studies of circulating tumor cells (CTCs) from peripheral blood, using a new technology developed at MGH. Our hope is that this "CTC-Chip" may have clinical usefulness for cancer patients. In addition to seeing patients, Dr. Lee is also interested in clinical trials of new drugs to treat genitourinary cancers.

BOOK AN

Appointment